U.S. Airlines Stock News

NasdaqGM:NVTS
NasdaqGM:NVTSSemiconductor

Why Navitas Semiconductor (NVDA) Is Back In The Spotlight

Navitas Semiconductor (NVTS) is drawing attention ahead of its planned appearance at Rosenblatt's 6th Annual Technology Summit, The Age of AI. Investors hope to hear more about its AI power chip roadmap. See our latest analysis for Navitas Semiconductor. That interest has come on the back of strong recent momentum in Navitas Semiconductor, with a 7 day share price return of 10.71% and a 30 day share price return of 27.23% at a last close of US$14.58. The year to date share price return of...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Will Narrowing Six‑Month Losses Shape Intellia Therapeutics' (NTLA) Gene‑Editing Investment Narrative?

In the second quarter of 2026, Intellia Therapeutics reported a net loss of US$106.63 million, with basic loss per share from continuing operations of US$0.80, while its six‑month net loss reached US$202.87 million and basic loss per share was US$1.61, both reflecting reduced losses versus a year earlier. The combination of a slightly higher quarterly net loss but improved loss per share, alongside a smaller half‑year net loss, may influence how investors assess Intellia’s progress in...
NasdaqGS:RRR
NasdaqGS:RRRHospitality

How Weaker Earnings and a Steady Dividend at Red Rock Resorts (RRR) Have Changed Its Investment Story

In early August 2026, Red Rock Resorts, Inc. reported lower quarterly and half-year revenue and net income versus a year earlier, while its board declared a US$0.26 per Class A share cash dividend for the second quarter, payable on September 30, 2026 to holders of record on September 15, 2026. The combination of softer earnings and a maintained dividend, alongside fresh discounted cash flow analysis pointing to potential undervaluation, raises questions about how Red Rock Resorts balances...
NYSE:NIO
NYSE:NIOAuto

Is Nio’s Capital-Intensive Battery Swap Bet Outrunning Investor Appetite For Risk In NIO (NIO)?

D.E. Shaw cut its Nio stake by 52.5% in the second quarter, while Nio reported continued strength in ES8 deliveries and raised the registered capital of its Wuhan energy subsidiary very significantly to support its battery swap and charging operations. This combination of a large institutional investor exiting and Nio doubling down on its infrastructure-heavy, partner-based battery swap model highlights a tension between investor caution and the company’s capital-intensive growth...
NYSE:UMH
NYSE:UMHResidential REITs

Why Everyone Is Watching UMH Properties (UMH) Now

Erez REIT Opportunities LP has publicly challenged UMH Properties (UMH), arguing the stock trades below its net asset value and urging the Board to review options, including a possible sale and wider governance changes. See our latest analysis for UMH Properties. The activist interest from Erez REIT Opportunities comes after a period where UMH Properties has seen a 6.11% 90 day share price return and a 9.54% 1 year total shareholder return, suggesting momentum has been building rather than...
NasdaqGS:SKHY
NasdaqGS:SKHYSemiconductor

SK hynix (NasdaqGS:SKHY) Cross Lists On Nasdaq, Is The Stock Still Cheap?

SK hynix cross listing puts fresh focus on stock SK hynix (NasdaqGS:SKHY) has drawn fresh investor attention after cross listing on the Nasdaq and raising US$26.5b, the largest foreign company listing in US markets to date. See our latest analysis for SK hynix. The fresh Nasdaq listing has coincided with strong short term momentum in SK hynix, with a 7 day share price return of 26.68% and a 30 day share price return of 11.26% at a latest share price of US$171.38. The year to date share price...
NYSE:ASA
NYSE:ASACapital Markets

Will Activist’s Governance Challenge and Mining-Skill Concerns Change ASA Gold and Precious Metals' (ASA) Narrative

On August 14, 2026, activist investor Alexander Merk filed an exempt solicitation with the SEC, challenging ASA Gold and Precious Metals Limited’s governance and highlighting the board’s lack of precious metals mining expertise while sharing a dashboard tracking key metrics since the board took over management on July 1, 2026. This intervention spotlights a growing shareholder push for industry-specific expertise and more transparent oversight at a specialized precious metals investment...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

Why Is Sanmina's (SANM) Buyback-Fueled EPS Strength Reshaping Its Earnings Quality Narrative?

In recent days, Sanmina has been highlighted by analysts for an improving earnings outlook, supported by upward estimate revisions and continued share repurchases that have enhanced earnings per share. This renewed optimism contrasts with weaker peers in the industrials space, underscoring Sanmina’s relative resilience in electronics manufacturing services and its appeal to investors focused on earnings quality. We’ll now examine how this stronger earnings outlook and analyst optimism may...
NYSE:ELF
NYSE:ELFPersonal Products

e.l.f. Beauty (ELF) Raised Its 2027 Sales Outlook, Is The Upside Already Priced In?

e.l.f. Beauty (ELF) is back in focus after its 5 August earnings release, with first quarter results and a higher fiscal 2027 sales outlook giving investors fresh numbers to assess the stock. See our latest analysis for e.l.f. Beauty. The earnings release came after a strong run in e.l.f. Beauty’s share price, with a 27.10% 1 month share price return and a 76.78% 3 month share price return, even though the 1 year total shareholder return declined 24.31%. If you are looking for other growth...
NYSE:RVTY
NYSE:RVTYLife Sciences

Revvity (RVTY) Could Be 4% Undervalued After SuperFlex Launch And Q2 Update

Revvity (RVTY) has just introduced its SuperFlex prenatal screening system, a compact CE IVDR certified immunoassay platform aimed at lower volume labs, while investors also digest the company’s recent second quarter earnings update. See our latest analysis for Revvity. Revvity’s latest SuperFlex launch and steady second quarter earnings come against a backdrop of stronger momentum, with a 90 day share price return of 21.17% and a 1 year total shareholder return of 29.88%. However, the 5 year...
NYSE:SSB
NYSE:SSBBanks

SouthState Bank (SSB) Expands Into Government Contractor Banking Following A Fair Value Gap

SouthState Bank (SSB) drew fresh attention on 17 August 2026 after launching a Government Contractor Banking vertical and appointing veteran banker and former MartinFederal Consulting CEO David Mathis to lead the effort. See our latest analysis for SouthState Bank. SouthState Bank’s latest move into Government Contractor Banking comes as momentum in the stock has been building, with a 90-day share price return of 20.42% and a 1-year total shareholder return of 18.35%. If you are looking for...
NYSE:BKV
NYSE:BKVOil and Gas

The Bull Case For BKV (BKV) Could Change Following Strong H1 2026 Output And Profitability Trends

BKV Corporation recently reported its second-quarter and first-half 2026 results, with quarterly sales rising to US$74.36 million and production increasing to 89,021 MMcfe, even as quarterly net income eased to US$75.81 million and earnings per share from continuing operations softened compared with a year earlier. Over the first six months of 2026, BKV’s revenue climbed to US$898.38 million and net income to US$119.88 million, highlighting stronger year-to-date profitability and higher...
NasdaqGS:AVPT
NasdaqGS:AVPTSoftware

Stronger Guidance and New AI Tools Might Change The Case For Investing In AvePoint (AVPT)

AvePoint recently reported second-quarter 2026 results showing revenue of US$124.5 million and net income of US$27.57 million, and issued third-quarter and full-year 2026 revenue guidance of US$128.2 million to US$130.2 million and US$508.5 million to US$512.5 million, respectively. The company also launched its Kinetic Classification and enhanced Rapid Recovery capabilities, tightening the link between AI-driven data governance and incident response across multi-cloud environments. We’ll...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

How Investors Are Reacting To Zoetis (ZTS) Cut Guidance Flat Q2 Results And New FDA EUA

Zoetis recently reported second-quarter 2026 results showing essentially flat year-on-year sales at US$2,468 million and slightly lower net income of US$691 million, alongside a full-year 2026 guidance cut to revenue of US$9.12–US$9.32 billion and diluted EPS of US$5.55–US$5.65. Around the same time, Zoetis secured an FDA Emergency Use Authorization for Simparica Trio against New World screwworm in dogs and appointed experienced life sciences executive Jay Saccaro as both CFO and COO,...
NasdaqGS:CVLT
NasdaqGS:CVLTSoftware

Commvault Systems (CVLT) Could Be 10% Undervalued As Cloud Rewind Expands Azure Coverage

Commvault Systems (CVLT) is back in focus after announcing upgrades to its Cloud Rewind product that triple Microsoft Azure resource coverage for configuration protection and recovery, strengthening the connection between its software and large cloud workloads. See our latest analysis for Commvault Systems. The Cloud Rewind announcement comes after a strong 90 day share price return of 41.53% and a year to date share price return of 16.22%, while the 1 year total shareholder return declined...
NYSE:IVZ
NYSE:IVZCapital Markets

Invesco Stock And 2 Asset Managers Riding The Bond ETF Reset

Global bond markets are back in the spotlight as long term yields climb to levels not seen in decades, squeezing borrowers and shaking assumptions about inflation, debt and equity valuations. That shift is creating fresh winners and losers across the ETF and index world. This article looks at three stocks from a Global Sovereign Bond ETF Issuers & Fixed-Income Index Providers screener that appear well placed, and explains why their exposure to this rate shock matters for your portfolio. The...
NYSE:CTRI
NYSE:CTRIConstruction

Did Centuri’s New Awards, Guidance Hike and Leadership Shuffle Just Shift Centuri Holdings' (CTRI) Investment Narrative?

In August 2026, Centuri Holdings, Inc. reported second-quarter 2026 revenue of US$961.99 million and net income of US$6.10 million, raised full-year 2026 revenue guidance to a range of US$3.59 billion to US$3.79 billion, and previously announced more than US$475 million of new commercial awards supporting its Vision One Centuri plan. Alongside these results, Centuri reshaped its leadership bench by appointing veteran energy executive Kelly Youngblood as Chief Financial Officer and Danielle...
NYSE:POST
NYSE:POSTFood

Why Post Holdings (POST) Is Back In The Spotlight

Post Holdings (POST) has given investors fresh numbers to assess. The company reported third quarter earnings on August 6, 2026, along with an update on a recently completed share repurchase program. See our latest analysis for Post Holdings. Post Holdings shares have been under pressure, with the share price down 20.36% year to date and the 1 year total shareholder return declining 26.43%, even after a 4.09% gain over the past week following the third quarter earnings and buyback update. If...
NasdaqGS:LLYV.K
NasdaqGS:LLYV.KEntertainment

Liberty Live Holdings (LLYV.K) Reports Wider Quarterly Loss, Is The Premium Still Justified?

Liberty Live Holdings (LLYV.K) reported second quarter 2026 results with revenue of US$147.06 million and a net loss of US$268.66 million, representing a wider loss than the prior year period. See our latest analysis for Liberty Live Holdings. Despite the wider quarterly loss, Liberty Live Holdings’ share price has a 25.6% year-to-date share price return and a 212.7% three-year total shareholder return, which suggests positive longer term momentum alongside short term swings around...
NYSE:MTRN
NYSE:MTRNMetals and Mining

Is Materion (MTRN) Undervalued As Stronger Earnings Lift The Valuation Debate?

Materion (MTRN) reported its second quarter and first half 2026 results, highlighting higher sales and net income compared with the same periods in 2025. These earnings figures provide investors with new data on profitability trends. See our latest analysis for Materion. The positive earnings update has arrived during a strong run for Materion, with the share price at $287.79 and a 30 day share price return of 17.41% supporting already very strong 1 year total shareholder returns of 156.09%...
NasdaqGS:FRSH
NasdaqGS:FRSHSoftware

Stronger Outlook And FedRAMP Progress Might Change The Case For Investing In Freshworks (FRSH)

Earlier this month, Freshworks Inc. reported second-quarter 2026 results showing US$237.38 million in sales and a shift to US$3.24 million in net income, while also raising its full-year revenue guidance to a range of US$963.5 million to US$966.5 million and providing third-quarter guidance. Freshworks also announced that its AI-powered Freshservice platform has reached FedRAMP “In-Process” status for Class C (Moderate), highlighting a pathway into U.S. federal government workloads and...
NYSE:H
NYSE:HHospitality

Hyatt Hotels (H) Enters Guyana As Growth Narrative Keeps Valuation In Focus

Hyatt Hotels (H) is expanding into Guyana through a partnership with RJR Investments & Holdings Inc., adding Atlantic Suites Hotel to its portfolio and planning a US$50 million Hyatt Regency Georgetown project by 2028. See our latest analysis for Hyatt Hotels. Hyatt Hotels shares have had a mixed few months, with a 30-day share price return that declined 4.75%. However, the 1-year total shareholder return of 29.70% and 5-year total shareholder return of 157.63% point to momentum that has been...
NYSE:TNET
NYSE:TNETProfessional Services

TriNet Group (TNET) Could Be 65% Below Fair Value On A Wide DCF Gap

How TriNet Group Stock Has Been Trading TriNet Group (TNET) has drawn attention after recent trading showed mixed short term moves. The stock declined 2.3% over the past day and was slightly lower over the past week. Over the past month, TriNet Group returned 12.7%, while the past 3 months show a gain of 57.4%. Year to date the stock is up 17.4%, with a 1 year total return of 4.7%. See our latest analysis for TriNet Group. Short term momentum for TriNet Group has cooled after strong recent...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Adaptive Biotechnologies (ADPT) Rebounds Sharply, Is The Stock Already Priced Fairly?

Adaptive Biotechnologies (ADPT) has drawn fresh attention after recent share price moves, with the stock last closing at $24.77. Investors are weighing this valuation against the company’s immune medicine platform and oncology testing focus. See our latest analysis for Adaptive Biotechnologies. The recent share price recovery in Adaptive Biotechnologies has been strong, with a 90 day share price return of 91.13% and a 1 year total shareholder return of 99.60%. This builds on a 3 year total...